Market Leads & Opportunities

United Kingdom-Cheshire: NHS Framework Agreement for Glatiramer acetate injection – North of England – Framework Lead

Source: Tracker Intelligence

The current contract for NHS Framework Agreement for Glatiramer acetate injection – North of England – Framework Lead is projected to end on 28-FEB-22 and may be available for retender. NHS Framework Agreement for the supply of Glatiramer Acetate injection to the North of England region.
Offer reference number: CM/PHR/18/5565
Period of Framework Agreement: 1.9.2018 – 29.2.2020 with an option to extend at the Authority’s discretion for up to 24 months.
The Framework is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.